A missense variant in the nuclear export signal of the FMR1 gene causes intellectual disability.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
05 Feb 2021
Historique:
received: 02 03 2020
revised: 14 10 2020
accepted: 04 11 2020
pubmed: 13 11 2020
medline: 20 1 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

Fragile X syndrome (FXS) is the most common monogenetic cause of intellectual disability and autism spectrum disorders. Mostly, FXS is caused by transcriptional silencing of the FMR1 gene due to a repeat expansion in the 5' UTR, and consequently lack of the protein product FMRP. However, in rare cases FXS is caused by other types of variants in the FMR1 gene. We describe a missense variant in the FMR1 gene, identified through whole-exome sequencing, in a boy with intellectual disability and behavioral problems. The variant is located in the FMRP's nuclear export signal (NES). We performed expression and localization studies of the variant in hair roots and HEK293 cells. Our results show normal expression but significant retention of the FMRP in the cells' nucleus. This finding suggests a possible FMRP reduction at its essential functional sites in the dendrites and the synaptic compartments and possible interference of other cellular processes in the nucleus. Together, this might lead to a FXS phenotype in the boy.

Identifiants

pubmed: 33181255
pii: S0378-1119(20)30967-7
doi: 10.1016/j.gene.2020.145298
pii:
doi:

Substances chimiques

5' Untranslated Regions 0
FMR1 protein, human 0
Nuclear Export Signals 0
Fragile X Mental Retardation Protein 139135-51-6

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145298

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Shimriet Zeidler (S)

Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands. Electronic address: s.zeidler@erasmusmc.nl.

Lies Anne Severijnen (LA)

Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Helen de Boer (H)

Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Esmay C van der Toorn (EC)

Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Claudia A L Ruivenkamp (CAL)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Emilia K Bijlsma (EK)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Rob Willemsen (R)

Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH